We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Automation of Luminescence-Based CYP Inhibition Assays Scientific Poster

SEARCH POSTERS

Abstract

Brad Larson1, Peter Banks1, Jason Greene1, Sarah Shultz2, Jim Cali2, Mary Sobol2 and Simon Allard2
1BioTek Instruments, Inc., Winooski, VT
2Promega Corporation, Madison, WI

The ability to determine the effects that lead compounds have on cytochrome P450 enzymes is an important part of today's drug discovery routine. One desired component of this process is the ability to profile enzymes using the same basic procedure. The second is an easy, yet dependable way to dilute compounds that will create accurate titration curves. Here we demonstrate the automation of dose-response curves using BioTek's Precision™ XS automated pipetting system. IC50s of small molecule drugs were determined using recombinant CYP isoforms 3A4, 2C9 and 2D6 and luminogenic substrates specific to each from Promega's P450-Glo™ CYP450 Screening Systems. Compounds were profiled against all three isoforms on the same 384-well assay plate to demonstrate the ease of this combined procedure.

Document Icon Download the poster PDF (545kb)

  • Part# PS090
  • Printed in USA.
Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom